J. Ottaway

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 1998 · 623 citations

Medicine, Oncology, Pharmacotherapy +10

Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Michael J. Moore, John Hamm, Janet Dancey et al. · Journal of Clinical Oncology · 2003 · 397 citations

Medicine, Oncology, Pharmacology +10

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

Graeme Duncan, Joel B. Epstein, Dongsheng Tu et al. · Head & Neck · 2005 · 152 citations

Pharmacy, Oncology, Radiation Oncology +17

Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5

Wendy R. Parulekar, Andrew G. Day, J. Ottaway et al. · Journal of Clinical Oncology · 2005 · 131 citations · Full text

Medicine, Oncology, Pharmacology +11

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

Nevin Murray, Robert B. Livingston, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1999 · 128 citations

Medicine, Oncology, Radiation Oncology +14